Prot. CP40617 - A Phase III, Multicenter, Randomized, Double-Blind, Active-Controlled Study to Assess the Efficacy and Safety of Baloxavir Marboxil in Combination with a Neuraminidase Inhibitor versus a Neuraminidase Inhibitor Alone in Hospitalized Patien

Project: Research project

StatusActive
Effective start/end date2/22/192/22/22

Funding

  • Syneos Health, Inc. (Prot. CP40617)
  • Genentech, Inc. (Prot. CP40617)